Apigenin ameliorates imiquimod-induced psoriasis in C57BL/6J mice by inactivating STAT3 and NF-κB

[1]  L. Ferris,et al.  Electrophilic nitro-fatty acids suppress psoriasiform dermatitis: STAT3 inhibition as a contributory mechanism , 2021, Redox biology.

[2]  K. Sayama,et al.  Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes. , 2021, Journal of dermatological science.

[3]  A. Nadeem,et al.  Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice. , 2020, Biochimie.

[4]  Sang-Hyun Kim,et al.  Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1/Th17 cell population and keratinocyte activation. , 2020, International immunopharmacology.

[5]  A. Nadeem,et al.  Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells. , 2020, European journal of pharmacology.

[6]  T. Tsai,et al.  Evolution of the inclusion/exclusion criteria and primary endpoints in pivotal trials of biologics and small oral molecules for the treatment of psoriasis , 2020, Expert review of clinical pharmacology.

[7]  Nan-Lin Wu,et al.  Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides , 2020, Scientific Reports.

[8]  P. Gisondi,et al.  The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  A. Nadeem,et al.  Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. , 2020, International immunopharmacology.

[10]  Chunhua Huang,et al.  Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. , 2019, Pharmacological research.

[11]  Hyungwoo Kim,et al.  Anti-inflammatory effects of a methanol extract of Dictamnus dasycarpus Turcz. root bark on imiquimod-induced psoriasis , 2019, BMC Complementary and Alternative Medicine.

[12]  K. Eyerich,et al.  Psoriasis Pathogenesis: Keratinocytes Are Back in the Spotlight. , 2019, The Journal of investigative dermatology.

[13]  Ting Wang,et al.  Silencing KRT16 inhibits keratinocyte proliferation and VEGF secretion in psoriasis via inhibition of ERK signaling pathway , 2019, The Kaohsiung journal of medical sciences.

[14]  A. Nadeem,et al.  Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  C. Albanesi,et al.  The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis , 2018, Front. Immunol..

[16]  C. Supuran,et al.  Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors , 2018, International journal of molecular sciences.

[17]  Josip Madunić,et al.  Apigenin: A dietary flavonoid with diverse anticancer properties. , 2018, Cancer letters.

[18]  Heng Li,et al.  Topical administration of reversible SAHH inhibitor ameliorates imiquimod‐induced psoriasis‐like skin lesions in mice via suppression of TNF‐&agr;/IFN‐&ggr;‐induced inflammatory response in keratinocytes and T cell‐derived IL‐17 , 2017, Pharmacological research.

[19]  G. D’Onofrio,et al.  Apigenin as neuroprotective agent: Of mice and men , 2018, Pharmacological research.

[20]  W. Boehncke,et al.  Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment , 2018, Clinical Reviews in Allergy & Immunology.

[21]  Y. Seo,et al.  Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway , 2017, Journal of Neuroinflammation.

[22]  G. D’Orazi,et al.  Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death , 2017, Journal of experimental & clinical cancer research : CR.

[23]  A. Nadeem,et al.  IL‐17A causes depression‐like symptoms via NF&kgr;B and p38MAPK signaling pathways in mice: Implications for psoriasis associated depression , 2017, Cytokine.

[24]  A. Nadeem,et al.  GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model. , 2017, Cellular signalling.

[25]  Wei Cheng,et al.  Apigenin inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells. , 2017, Oncology reports.

[26]  Ningfei Li,et al.  Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells , 2017, International journal of molecular medicine.

[27]  A. Nadeem,et al.  Psoriatic inflammation enhances allergic airway inflammation through IL‐23/STAT3 signaling in a murine model , 2017, Biochemical pharmacology.

[28]  Yan Wang,et al.  Suppressive effect of β,β-dimethylacryloyl alkannin on activated dendritic cells in psoriasis by the TLR7/8 pathway. , 2016, International immunopharmacology.

[29]  I. McInnes,et al.  Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases. , 2016, Annual review of medicine.

[30]  M. Nagarkatti,et al.  Apigenin, a Natural Flavonoid, Attenuates EAE Severity Through the Modulation of Dendritic Cell and Other Immune Cell Functions , 2016, Journal of Neuroimmune Pharmacology.

[31]  A. Nadeem,et al.  Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation. , 2015, Pharmacological research.

[32]  Dong Yu,et al.  A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. , 2013, The Journal of investigative dermatology.

[33]  A. Eidi,et al.  Antinociceptive and anti-inflammatory effects of olive oil (Olea europeae L.) in mice , 2012, Pharmaceutical biology.

[34]  Gang Wang,et al.  IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms. , 2011, The Journal of investigative dermatology.

[35]  Y. Hwang,et al.  The flavonoids apigenin and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells. , 2011, Journal of dermatological science.

[36]  J. Krueger,et al.  New insights in the immunologic basis of psoriasis. , 2010, Seminars in cutaneous medicine and surgery.

[37]  S. P. Srinivas,et al.  Measurement and Modeling of Diffusion Kinetics of a Lipophilic Molecule Across Rabbit Cornea , 2010, Pharmaceutical Research.

[38]  Michael Liu,et al.  Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells , 2009, Arthritis research & therapy.

[39]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. , 2008, Journal of the American Academy of Dermatology.

[40]  K. Hashimoto,et al.  Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor‐β , 1990 .